Hester Biosciences Limited – NSE:HESTERBIO.NS

Hester Biosciences Limited stock price today

INR 2,531.05
+132.60
+5.53%
Financial Health
0
1
2
3
4
5
6
7
8
9

Hester Biosciences Limited stock price monthly change

-10.66%
month

Hester Biosciences Limited stock price quarterly change

-10.66%
quarter

Hester Biosciences Limited stock price yearly change

+65.91%
year

Hester Biosciences Limited key metrics

Market Cap
20.26B
Enterprise value
22.70B
P/E
86.93
EV/Sales
7.27
EV/EBITDA
31.52
Price/Sales
6.53
Price/Book
6.75
PEG ratio
150.44
EPS
23.9
Revenue
3.04B
EBITDA
642.76M
Income
188.89M
Revenue Q/Q
17.76%
Revenue Y/Y
14.45%
Profit margin
7.52%
Oper. margin
15.78%
Gross margin
51.89%
EBIT margin
15.78%
EBITDA margin
21.11%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Hester Biosciences Limited stock price history

Hester Biosciences Limited stock forecast

Hester Biosciences Limited financial statements

Hester Biosciences Limited (NSE:HESTERBIO.NS): Profit margin
Jun 2023 878.53M 58.69M 6.68%
Sep 2023 704.55M 40.86M 5.8%
Dec 2023 669.83M 39.84M 5.95%
Mar 2024 792.55M 49.5M 6.25%
0.25%
Yield TTM
Hester Biosciences Limited (NSE:HESTERBIO.NS): Payout ratio
Payout ratio 0%
Hester Biosciences Limited (NSE:HESTERBIO.NS): Dividend Yield
2016 1.21%
2017 0.54%
2019 0.79%
2020 0.92%
2022 0.37%
Hester Biosciences Limited (NSE:HESTERBIO.NS): Debt to assets
Jun 2023 0 0
Sep 2023 6830310000 3.91B 57.32%
Dec 2023 0 0
Mar 2024 6623470000 3.59B 54.27%
Hester Biosciences Limited (NSE:HESTERBIO.NS): Cash Flow
Jun 2023 107.98M 0 0
Sep 2023 85.68M 0 0
Dec 2023 74.98M 0 0
Mar 2024 0 0 0

Hester Biosciences Limited alternative data

Hester Biosciences Limited (NSE:HESTERBIO.NS): Employee count
Aug 2023 584
Sep 2023 693
Oct 2023 693
Nov 2023 693
Dec 2023 693
Jan 2024 693
Feb 2024 693
Mar 2024 693
Apr 2024 693
May 2024 693
Jun 2024 693
Jul 2024 693

Hester Biosciences Limited other data

  • What's the price of Hester Biosciences Limited stock today?

    One share of Hester Biosciences Limited stock can currently be purchased for approximately $2,531.05.

  • When is Hester Biosciences Limited's next earnings date?

    Unfortunately, Hester Biosciences Limited's (HESTERBIO.NS) next earnings date is currently unknown.

  • Does Hester Biosciences Limited pay dividends?

    Yes, Hester Biosciences Limited pays dividends and its trailing 12-month yield is 0.25% with 0% payout ratio. The last Hester Biosciences Limited stock dividend of $0 was paid on 4 Sep 2025.

  • How much money does Hester Biosciences Limited make?

    Hester Biosciences Limited has a market capitalization of 20.26B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 29.59% to 3.05B US dollars.

  • What is Hester Biosciences Limited's stock symbol?

    Hester Biosciences Limited is traded on the NSE under the ticker symbol "HESTERBIO.NS".

  • What is Hester Biosciences Limited's primary industry?

    Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.

  • How do i buy shares of Hester Biosciences Limited?

    Shares of Hester Biosciences Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Hester Biosciences Limited have?

    As Jul 2024, Hester Biosciences Limited employs 693 workers.

  • When Hester Biosciences Limited went public?

    Hester Biosciences Limited is publicly traded company for more then 10 years since IPO on 13 Mar 2015.

  • What is Hester Biosciences Limited's official website?

    The official website for Hester Biosciences Limited is hester.in.

  • How can i contact Hester Biosciences Limited?

    Hester Biosciences Limited can be reached via phone at +91 79 2644 5107.

Hester Biosciences Limited company profile:

Hester Biosciences Limited

hester.in
Exchange:

NSE

Full time employees:

642

Industry:

Drug Manufacturers - Specialty & Generic

Sector:

Healthcare

Hester Biosciences Limited manufactures and trades in veterinary vaccines and animal health products in India and internationally. It operates in two segments, Poultry Healthcare and Animal Healthcare. The company provides poultry vaccines for diseases, such as newcastle disease, infectious bronchitis, infectious bursal disease, fowl pox, egg drop syndrome, reo, marek's disease, infectious coryza, fowl cholera, mycoplasma gallisepticum, inclusion body hepatitis, avian encephalomyelitis, etc. It also offers vaccines for large animals comprising Goat Pox, Peste des Petits Ruminants, Brucellosis, Mastitis, Metritis, and various infectious diseases, as well as infections, reproductive disorders, theileriosis, parasitic diseases, etc. In addition, the company provides feed supplements, such as toxin binder, trace minerals, enzyme preparation, and bypass fat; disinfectants for farms and equipment, and water sanitizers; nutrition products consisting of mineral mixtures, fertility supplements, and growth tonics; and herbal products, including growth promoters, herbal replacers for choline chloride, stress relievers and immunity boosters, respiratory stimulants, liver tonics, wound healing preparations, uterine tonics, digestive tonics and anti-bloat solutions, ectoparasiticide preparations, anti-mastitis, and anti-prolapse preparations. Hester Biosciences Limited was incorporated in 1987 and is headquartered in Ahmedabad, India.

Pushpak
Ahmedabad, 380006

:
ISIN: INE782E01017
CUSIP: Y3180C102